Skip to main content

Epilepsy: Cannabis

Question for Department of Health and Social Care

UIN 8147, tabled on 27 January 2020

To ask the Secretary of State for Health and Social Care, what his policy is on the availability of medicinal cannabis prescriptions for children with epilepsy; and if he will make a statement.

Answered on

4 February 2020

On 1 November 2018, the law was changed to allow clinicians on the General Medical Council’s (GMC) Specialist Register to prescribe cannabis-based products for medicinal use, where clinically appropriate and in the best interests of patients.

On 20 December 2019 a letter was published on the NHS England and NHS Improvement website reminding prescribers of the GMC’s guidance on the prescribing and use of unlicensed medicines – and to clarify the procedure for prescribing and supplying cannabis-based products for medicinal use. Licensed cannabis-based products indicated for epilepsy, such as Epidyolex, may be prescribed in-line with the condition of the marketing authorisation. The letter is available at the following link:

https://www.england.nhs.uk/wp-content/uploads/2019/12/guidance-prescribing-cannabis-based-products-medicinal-use.pdf